Your browser doesn't support javascript.
loading
The role of sex differences in depression in pathologically defined Alzheimer's disease.
Tremblay, Cécilia; Choudhury, Parichita; Belden, Christine M; Goldfarb, Danielle; Lorenzini, Ileana; Beach, Thomas G; Serrano, Geidy E.
Afiliação
  • Tremblay C; Department of Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, United States.
  • Choudhury P; Department of Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, United States.
  • Belden CM; Department of Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, United States.
  • Goldfarb D; Department of Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, United States.
  • Lorenzini I; Department of Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, United States.
  • Beach TG; Department of Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, United States.
  • Serrano GE; Department of Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, United States.
Front Aging Neurosci ; 15: 1156764, 2023.
Article em En | MEDLINE | ID: mdl-37234269
ABSTRACT

Introduction:

Sex differences in Alzheimer's disease (AD) may contribute to disease heterogeneity and affect prevalence, risk factors, disease trajectories and outcomes. Depression impacts a large number of patients with AD and has been reported to be more prevalent in women. We aimed to better understand the interaction between sex, depression and AD neuropathology, which could have implications for detection of symptoms, earlier diagnosis, therapeutic management, and enhanced quality of life.

Methods:

We compared 338 cases with clinicopathologically confirmed AD (46% women) to 258 control cases (50% women), without dementia, parkinsonism or a significant pathological diagnosis. Depression was assessed both, using the Hamilton Depression Scale (HAM-D), and as being reported in their medical history combined with treatment with antidepressant medication.

Results:

In the control group, women showed a higher depression severity, and a higher proportion of women were found to meet the cut-off score for depression on the HAM-D (32 vs. 16%) and having an history of depression (33 vs. 21%), while these sex differences were not observed in AD. Further, in both groups, female sex independently predicted the presence of depression, with covariates for age and cognitive status. AD subjects had higher mean HAM-D scores, were more likely to meet cutoff scores for depression (41 vs. 24%) and have a history of depression than controls (47 vs. 27%). When comparing the increase in frequency of depression in controls versus AD, the difference was significantly greater in men (AD men - control men 24%) than in women (AD women - control women 9%). Although subjects with depression were more likely to have higher levels of AD neuropathology, these differences were not observed when investigating the control or AD group separately.

Discussion:

Control women had a higher likelihood and severity of depression than control men, but this sex difference was not noted when considering only those with pathologically defined AD, emphasizing the importance of considering sex in aging studies. AD was associated with higher rates of depression and men may be more likely to report or be diagnosed with depression once they develop AD indicating the importance of more frequent depression screenings in men.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos